Total returns on £1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
Fund/benchmark | Change | |
---|---|---|
Price | The Biotech Growth Trust PLC (Ordinary Share) | -22.06% |
NAV | The Biotech Growth Trust PLC (Ordinary Share) | -22.48% |
Morningstar's Benchmark | NASDAQ Biotechnology TR GBP | -- |
- The Biotech Growth Trust PLC - Transaction in Own Shares
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Total Voting Rights
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Transaction in Own Shares
- The Biotech Growth Trust PLC - Net Asset Value(s)
- The Biotech Growth Trust PLC - Net Asset Value(s)
More ▼
Key statistics
On Friday, The Biotech Growth Trust PLC (BIOG:LSE) closed at 748.00, 22.08% above the 52 week low of 612.70 set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Shares outstanding | 25.92m |
---|---|
Market cap | 185.55m GBP |
Total assets | 213.11m GBP |
Total expense ratio | 1.12% |
High | 748.00 |
Low | 736.00 |
Previous close | 742.00 |
Average volume | 133.29k |
---|---|
YTD Change | -12.51% |
Beta | 0.4500 |
Diluted NAV (est) | 808.25 |
Diluted NAV (last pub) | 806.85 |
Premium/Discount | -7.45% |
Net Gearing | +7.19% |
Data delayed at least 20 minutes, as of Jul 04 2025 16:35 BST.
More ▼